Tokyo Tape
Sign in
← Kringle Pharma

Annual report

4884.TEDINET S100XBJD
Period2024-10-01 → 2025-09-30
Filed2025-12-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 77
MetricValuePeriodScopeSource row
Revenue¥72m2024-10-01 → 2025-09-30StandaloneNet sales
Revenue¥80m2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥69m2022-10-01 → 2023-09-30vStandaloneNet sales (5-year summary)
Revenue¥392m2021-10-01 → 2022-09-30vStandaloneNet sales (5-year summary)
Revenue¥290m2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Operating income−¥909m2024-10-01 → 2025-09-30StandaloneOperating income
Operating income−¥818m2023-10-01 → 2024-09-30StandaloneOperating income
Ordinary income−¥915m2024-10-01 → 2025-09-30StandaloneOrdinary income
Ordinary income−¥755m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥853m2022-10-01 → 2023-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥330m2021-10-01 → 2022-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥300m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥915m2024-10-01 → 2025-09-30StandaloneIncome before income taxes
Profit before tax−¥755m2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Net income−¥916m2024-10-01 → 2025-09-30StandaloneProfit loss
Net income−¥756m2023-10-01 → 2024-09-30StandaloneProfit loss
Net income−¥854m2022-10-01 → 2023-09-30vStandaloneNet income loss (5-year summary)
Net income−¥332m2021-10-01 → 2022-09-30vStandaloneNet income loss (5-year summary)
Net income−¥301m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Total assets¥2.1bnat 2025-09-30StandaloneAssets
Total assets¥2.8bnat 2024-09-30StandaloneAssets
Total assets¥2.6bnat 2023-09-30vStandaloneTotal assets (5-year summary)
Total assets¥3.2bnat 2022-09-30vStandaloneTotal assets (5-year summary)
Total assets¥2.6bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥770mat 2025-09-30StandaloneLiabilities
Total liabilities¥649mat 2024-09-30StandaloneLiabilities
Net assets / equity¥1.3bnat 2025-09-30StandaloneNet assets
Net assets / equity¥2.1bnat 2024-09-30StandaloneNet assets
Net assets / equity¥2.0bnat 2023-09-30vStandaloneNet assets
Net assets / equity¥2.8bnat 2022-09-30vStandaloneNet assets (5-year summary)
Net assets / equity¥2.5bnat 2021-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2025-09-30StandaloneCash and deposits
Cash and deposits¥2.3bnat 2024-09-30StandaloneCash and deposits
Cash & equivalents¥991mat 2025-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2023-09-30vStandaloneCash and cash equivalents
Cash & equivalents¥2.5bnat 2022-09-30vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.1bnat 2021-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥756m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥661m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥689m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥16m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥561m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥154m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥121m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥121m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥254m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥84m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥838m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥69m2022-10-01 → 2023-09-30vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥603m2021-10-01 → 2022-09-30vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥596m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-133.922024-10-01 → 2025-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-118.212023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-158.462022-10-01 → 2023-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-68.332021-10-01 → 2022-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-72.512020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥182.3at 2025-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥306.87at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥363.45at 2023-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥517.75at 2022-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥578.17at 2021-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio61.5%at 2025-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.8%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.6%at 2023-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio86.8%at 2022-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.1%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Shares issued7,018,200at 2025-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued6,810,700at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued5,522,200at 2023-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued5,380,700at 2022-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,334,700at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees17at 2025-09-30StandaloneNumber of employees
Employees15at 2024-09-30StandaloneNumber of employees
Employees13at 2023-09-30vStandaloneNumber of employees
Employees12at 2022-09-30vStandaloneNumber of employees
Employees11at 2021-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 770
ItemContextValueUnit
Capital surplusCurrentYearInstant_NonConsolidatedMember2888081000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-756453000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-1672709000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-756453000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-1672709000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-106000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-147000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2089944000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember1279402000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember18247000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember29853000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2108192000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember1309255000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2757113000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember2079363000JPY
Net salesPrior1YearDuration_NonConsolidatedMember80038000JPY
Net salesCurrentYearDuration_NonConsolidatedMember72215000JPY
Beginning finished goods cosPrior1YearDuration_NonConsolidatedMember－JPY
Beginning finished goods cosCurrentYearDuration_NonConsolidatedMember－JPY
Cost of products manufacturedPrior1YearDuration_NonConsolidatedMember－JPY
Cost of products manufacturedCurrentYearDuration_NonConsolidatedMember－JPY
Total beginning finished goods and cost of products manufactured for the periodPrior1YearDuration_NonConsolidatedMember－JPY
Total beginning finished goods and cost of products manufactured for the periodCurrentYearDuration_NonConsolidatedMember－JPY
Ending finished goods cosPrior1YearDuration_NonConsolidatedMember－JPY
Ending finished goods cosCurrentYearDuration_NonConsolidatedMember－JPY
Cost of finished goods soldPrior1YearDuration_NonConsolidatedMember－JPY
Cost of finished goods soldCurrentYearDuration_NonConsolidatedMember－JPY
Gross profitPrior1YearDuration_NonConsolidatedMember80038000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember72215000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember897920000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember981667000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-817882000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-909452000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember10000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember67000JPY
Subsidy income noiPrior1YearDuration_NonConsolidatedMember62011000JPY
Subsidy income noiCurrentYearDuration_NonConsolidatedMember－JPY
Revenue from reagent sales noiPrior1YearDuration_NonConsolidatedMember－JPY
Revenue from reagent sales noiCurrentYearDuration_NonConsolidatedMember1400000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember717000JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember－JPY
Interest on refund noiPrior1YearDuration_NonConsolidatedMember179000JPY
Interest on refund noiCurrentYearDuration_NonConsolidatedMember112000JPY
Other noiPrior1YearDuration_NonConsolidatedMember1000JPY
Other noiCurrentYearDuration_NonConsolidatedMember4000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember62920000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember1585000JPY
Share acquisition rights issuance costs noePrior1YearDuration_NonConsolidatedMember－JPY
Share acquisition rights issuance costs noeCurrentYearDuration_NonConsolidatedMember6645000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-09-30pass
balance sheet identitynon_consolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2025-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2025-09-30pass